EP1620084A1 - USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF L-DOPA INDUCED MOVEMENT DISORDERS, DYSKINESIAS, DRUG ADDICTION, PAIN AND CATARACT